Malignant Histiocytosis With PD-L1 Expression-Dramatic Response to Nivolumab
Malignant Histiocytosis With PD-L1 Expression-Dramatic Response to Nivolumab
About this item
Full title
Malignant Histiocytosis With PD-L1 Expression-Dramatic Response to Nivolumab
Author / Creator
Publisher
England: Elsevier, Inc
Journal title
Mayo Clinic proceedings, 2022-07, Vol.97 (7), p.1401-1403
Language
English
Formats
Publication information
Publisher
England: Elsevier, Inc
Subjects
More information
Alternative Titles
Full title
Malignant Histiocytosis With PD-L1 Expression-Dramatic Response to Nivolumab
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03959782v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03959782v1
Other Identifiers
ISSN
0025-6196
E-ISSN
1942-5546
DOI
10.1016/j.mayocp.2022.05.012